Who is sponsoring NCT02358967?

NCT02358967 is sponsored by Wayne State University.

What drugs are being tested in NCT02358967?

Interventions in NCT02358967: TRF (Tocotrienol-rich-fraction), Placebo.

What condition does NCT02358967 study?

NCT02358967 studies End Stage Renal Disease, Chronic Kidney Disease.

Is NCT02358967 still recruiting?

NCT02358967 is currently completed. Last updated 10 August 2022.

Last reviewed 2022-08-10 · How we verify

NCT02358967: PATCH

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Palm Tocotrienols in Chronic Hemodialysis (USA)

Completed NA Last updated 10 August 2022

What this trial tests

NA trial testing TRF (Tocotrienol-rich-fraction) in End Stage Renal Disease in 280 participants. Completed in 31 August 2020.

Timeline

15 June 2017

Primary endpoint
30 June 2020

31 August 2020

Quick facts

Lead sponsor	Wayne State University
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	quadruple
Primary purpose	other
Enrollment	280
Start date	15 June 2017
Primary completion	30 June 2020
Estimated completion	31 August 2020
Sites	1 location across United States

Drugs / interventions tested

TRF (Tocotrienol-rich-fraction)
Placebo

Conditions studied

End Stage Renal Disease — all drugs for End Stage Renal Disease →
Chronic Kidney Disease — all drugs for Chronic Kidney Disease →

Sponsor

Wayne State University

Who can join

18 and older, any sex, with End Stage Renal Disease or Chronic Kidney Disease. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Patients undergoing chronic hemodialysis are at increased risk for cardiovascular disease, attributed in part to increased oxidative stress, inflammation and dyslipidemia. Intervention with a naturally occurring dietary supplement may improve certain biomarkers of inflammation and oxidative stress and improve the lipid profile.

Publications & conference data

2 peer-reviewed publications reference this trial (live from Europe PMC):

A Food Frequency Questionnaire for Hemodialysis Patients in Bangladesh (BDHD-FFQ): Development and Validation.
Ahmed S, Rahman T, Ripon MSH, Rashid HU, et al · · 2021 · cited 11× · PMID 34960076 · DOI 10.3390/nu13124521
Dietary Patterns and Health Outcomes among African American Maintenance Hemodialysis Patients.
Tallman DA, Latifi E, Kaur D, Sulaheen A, et al · · 2020 · cited 11× · PMID 32197373 · DOI 10.3390/nu12030797

Verify or expand the search:

Other recruiting trials for End Stage Renal Disease

Currently open trials in the same condition.

NCT06257134 — Impact on Quality of Life of Symptoms Routine E-monitoring Among Dialysis Patients. · NA · recruiting
NCT06310161 — Light Therapy in End Stage Kidney Disease · NA · recruiting
NCT07360938 — Drug Interaction Potential of Pro-Inflammatory Conditions · recruiting
NCT06422871 — PReSeRVE-HD: Observational Study of the Merit HeRO® Graft and Super HeRO® in Patients on Hemodialysis · recruiting
NCT06861816 — Ventilatory Functions and Physical Intolerance in ESRD Adolescents: Response to Program of Walking With Dogs · NA · recruiting

Other Wayne State University trials

Trials by the same sponsor.

NCT07219394 — Peer-Delivered Behavioral Activation in a CCBHC · NA · recruiting
NCT07123467 — Cannabidiol-Assisted Learning for Managing Generalized Anxiety Disorder · Phase 3 · recruiting
NCT07222306 — Cannabis, Neuroinflammation, and Suicidal Ideation: A Supplemental Brain Imaging Study · enrolling by invitation
NCT05684978 — Efficacy and Safety of Perampanel in the Treatment of Refractory Status Epilepticus · Phase 4 · terminated
NCT06381180 — Warrior CARE: Cannabis Behavioral Health · Phase 1, PHASE2 · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT02358967 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Wayne State University
Last refreshed: 10 August 2022

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT02358967.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing